000 | 010760000a22003850004500 | ||
---|---|---|---|
008 | 110606t xxu||||| |||| 00| 0 eng d | ||
020 | _a9291681687 | ||
040 | _cVAD | ||
041 | _aEngels | ||
100 |
_aJager, Johannes _eed. |
||
245 | _aHepatitis C and injecting drug use : impact, costs and policy options [PDF] | ||
260 |
_aLisbon _bEMCDDA _c2004 |
||
300 | _a389 p. | ||
490 |
_aEMCDDA monographs _v7 |
||
650 | _abeleid | ||
650 | _adrugs | ||
650 | _aEuropa | ||
650 | _ahepatitis | ||
650 | _ahulpverlening | ||
650 | _ainfectieziekten | ||
650 | _ainjecterende druggebruikers | ||
650 | _amaatschappelijke kosten | ||
650 | _alever | ||
650 | _amethadon | ||
650 | _amonitoring | ||
650 | _aonderzoeksrapporten | ||
650 | _apreventie | ||
650 | _asomatische stoornissen | ||
650 | _aspuitenruil | ||
700 |
_aLimburg, Wien _eed. |
||
700 | _aKretzschmar,Mirjam | ||
700 | _aPostma, Maarten | ||
700 | _aWiessing, Lucas | ||
856 | _uhttp://www.google.com/search?q=Hepatitis-C-and-injecting-drug-use impact-costs | ||
999 |
_c18343 _d18343 |